D'ANDREA, GIOVANNA
D'ANDREA, GIOVANNA
Dipartimento di Medicina Clinica e Sperimentale
"Genetic modulation of oral anticoagulantion with warfarin "
2000-01-01 Margaglione, Maurizio; Colaizzo, D; D'Andrea, Giovanna; Brancaccio, V; Ciampa, A; Grandone, E; Diminno, G.
. Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib gene in a patient with a severe bleeding tendency. Thromb Haemost 1999, 81(4): 486-92
1999-01-01 Margaglione, M; D’Andrea, G; Grandone, E; Brancaccio, V; Amoriello, A; Di Minno, G
. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Thromb Haemost. 2002; 87(1):32-6.
2002-01-01 Margaglione, M; Bossone, A; Colaizzo, D; D'Andrea, G; Brancaccio, V; Ciampa, A; Grandone, E; Di Minno, G
. Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain. Haematologica. 89(8):979-84; 2004
2004-01-01 D'Andrea, G; Bossone, A; Lupone, Mr; Peyvandi, F; Maisto, G; Perricone, F; Grandone, E; Margaglione, M
. Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica 2004; 89(12):1510-6.
2004-01-01 D'Ambrosio, Rl; D'Andrea, G; Cappucci, F; Chetta, M; Di Perna, P; Brancaccio, V; Grandone, E; Margaglione, M
. The Methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutations. Thromb Haemost 1998; 79:907-911
1998-01-01 Margaglione, M; D’Andrea, G; D’Addedda, M; Giuliani, N; Cappucci, G; Iannaccone, L; Vecchione, G; Grandone, E; Brancaccio, V; Di Minno, G
. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation. Haematologica 2003; .88(3):286-9.
2003-01-01 Bossone, A; Cappucci, F; D'Andrea, G; Brancaccio, V; Cibelli, G; Iannaccone, L; Grandone, E; Margaglione, M
.A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 105(2):645-9; 2005
2005-01-01 D'Andrea, G; D'Ambrosio, Rl; Di Perna, P; Chetta, M; Santacroce, R; Brancaccio, V; Grandone, E; Margaglione, M
; GLAnzmann's Thrombasthenia Italian Team (GLATIT).Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost., 2002; 87(6):1034-42
2002-01-01 D'Andrea, G; Colaizzo, D; Vecchione, G; Grandone, E; Di Minno, G; Margaglione, M
A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions
2008-01-01 D'Andrea, G; Bafunno, V; DEL VECCHIO, L; Amoriello, A; Morabito, P; Vecchione, G; Grandone, E; Margaglione, M
A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
2008-01-01 D'Andrea, Giovanna; Bafunno, V.; DEL VECCHIO, L.; Amoriello, A.; Morabito, P.; Vecchione, G.; Grandone, E.; Margaglione, Maurizio
A MODEL TO PREDICT SUCCESS FOLLOWING PEG-INTERFERON AND RIBAVIRIN THERAPY FOR PATIENTS WITH HCV-1 INFECTION
2014-01-01 Ippolito, A. m.; Andriulli, A.; Angelico, M.; Nardi, A.; Di Marco, V.; Smedile, A.; Calvaruso, V.; Valvano, M. r.; Milella, M.; Morisco, F.; Fattovich, G.; Felder, M.; Brancaccio, P.; Fasano, Massimo; Gatti, P.; Andriulli, N.; Tundo, P.; Barone, M.; Cozzolongo, R.; D'Andrea, Giovanna; Mazzella, G.; Santantonio, TERESA ANTONIA
A myoferlin gain-of-function variant associates with a new type of hereditary angioedema
2020-01-01 Ariano, A.; D'Apolito, M.; Bova, M.; Bellanti, F.; Loffredo, S.; D'Andrea, G.; Intrieri, M.; Petraroli, A.; Maffione, A. B.; Spadaro, G.; Santacroce, R.; Margaglione, M.
A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme
2007-01-01 D'Ambrosio, R. L.; D'Andrea, Giovanna; Cafolla, A.; Faillace, F.; Margaglione, Maurizio
A novel allele variant of the SERPINF2 gene responsible for severe plasmin inhibitor (α2-antiplasmin) deficiency in an Italian patient
2018-01-01 Viganò, S; D'Andrea, G; Valle, Pd; Santacroce, R; Margaglione, M; D'Angelo, A.
A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency.
2003-01-01 D'Andrea, Giovanna; DI PERNA, P.; Brancaccio, V.; Faioni, E. M.; Castaman, G.; Cibelli, Giuseppe; DI MINNO, G.; Margaglione, Maurizio
A Novel KCNN2 Variant in a Family with Essential Tremor Plus: Clinical Characteristics and In Silico Analysis
2023-01-01 D'Apolito, Maria; Ceccarini, Caterina; Rosa, Savino; Adipietro, Iolanda; di Bari, Ighli; Santacroce, Rosa; Curcetti, Maria; D'Andrea, Giovanna; Croce, Anna-Irma; Cesarano, Carla; Polito, Anna Nunzia; Margaglione, Maurizio
A NOVEL NONSENSE TET2 MUTATION IN A PATIENT WITH PRIMARY MYELOFIBROSIS.
2013-01-01 D'Andrea, Giovanna; Dimatteo, C.; Girolamo, G. De; Longo, V.; Leccese, A.; Trunzo, R.; Santacroce, Rosa; Margaglione, Maurizio
A polymorfism in VKORC1 gene is associated with an interindividual variability in the dose-anticoagulation effect of warfarin.
2005-01-01 D'Andrea, Giovanna; Dambrosio, R. L.; P, DI ERNA .; Chetta, M.; Santacroce, Rosa; Brancaccio, V.; Grandone, E.; Margaglione, Maurizio
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
2005-01-01 D'Andrea, Giovanna; D'Ambrosio, Rl; Di Perna, P; Chetta, Massimiliano; Santacroce, Rosa; Brancaccio, V; Grandone, E; Margaglione, Maurizio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Genetic modulation of oral anticoagulantion with warfarin " | 1-gen-2000 | Margaglione, Maurizio; Colaizzo, D; D'Andrea, Giovanna; Brancaccio, V; Ciampa, A; Grandone, E; Diminno, G. | |
| . Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib gene in a patient with a severe bleeding tendency. Thromb Haemost 1999, 81(4): 486-92 | 1-gen-1999 | Margaglione, M; D’Andrea, G; Grandone, E; Brancaccio, V; Amoriello, A; Di Minno, G | |
| . FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile. Thromb Haemost. 2002; 87(1):32-6. | 1-gen-2002 | Margaglione, M; Bossone, A; Colaizzo, D; D'Andrea, G; Brancaccio, V; Ciampa, A; Grandone, E; Di Minno, G | |
| . Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain. Haematologica. 89(8):979-84; 2004 | 1-gen-2004 | D'Andrea, G; Bossone, A; Lupone, Mr; Peyvandi, F; Maisto, G; Perricone, F; Grandone, E; Margaglione, M | |
| . Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica 2004; 89(12):1510-6. | 1-gen-2004 | D'Ambrosio, Rl; D'Andrea, G; Cappucci, F; Chetta, M; Di Perna, P; Brancaccio, V; Grandone, E; Margaglione, M | |
| . The Methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutations. Thromb Haemost 1998; 79:907-911 | 1-gen-1998 | Margaglione, M; D’Andrea, G; D’Addedda, M; Giuliani, N; Cappucci, G; Iannaccone, L; Vecchione, G; Grandone, E; Brancaccio, V; Di Minno, G | |
| . The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation. Haematologica 2003; .88(3):286-9. | 1-gen-2003 | Bossone, A; Cappucci, F; D'Andrea, G; Brancaccio, V; Cibelli, G; Iannaccone, L; Grandone, E; Margaglione, M | |
| .A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 105(2):645-9; 2005 | 1-gen-2005 | D'Andrea, G; D'Ambrosio, Rl; Di Perna, P; Chetta, M; Santacroce, R; Brancaccio, V; Grandone, E; Margaglione, M | |
| ; GLAnzmann's Thrombasthenia Italian Team (GLATIT).Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost., 2002; 87(6):1034-42 | 1-gen-2002 | D'Andrea, G; Colaizzo, D; Vecchione, G; Grandone, E; Di Minno, G; Margaglione, M | |
| A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions | 1-gen-2008 | D'Andrea, G; Bafunno, V; DEL VECCHIO, L; Amoriello, A; Morabito, P; Vecchione, G; Grandone, E; Margaglione, M | |
| A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions. | 1-gen-2008 | D'Andrea, Giovanna; Bafunno, V.; DEL VECCHIO, L.; Amoriello, A.; Morabito, P.; Vecchione, G.; Grandone, E.; Margaglione, Maurizio | |
| A MODEL TO PREDICT SUCCESS FOLLOWING PEG-INTERFERON AND RIBAVIRIN THERAPY FOR PATIENTS WITH HCV-1 INFECTION | 1-gen-2014 | Ippolito, A. m.; Andriulli, A.; Angelico, M.; Nardi, A.; Di Marco, V.; Smedile, A.; Calvaruso, V.; Valvano, M. r.; Milella, M.; Morisco, F.; Fattovich, G.; Felder, M.; Brancaccio, P.; Fasano, Massimo; Gatti, P.; Andriulli, N.; Tundo, P.; Barone, M.; Cozzolongo, R.; D'Andrea, Giovanna; Mazzella, G.; Santantonio, TERESA ANTONIA | |
| A myoferlin gain-of-function variant associates with a new type of hereditary angioedema | 1-gen-2020 | Ariano, A.; D'Apolito, M.; Bova, M.; Bellanti, F.; Loffredo, S.; D'Andrea, G.; Intrieri, M.; Petraroli, A.; Maffione, A. B.; Spadaro, G.; Santacroce, R.; Margaglione, M. | |
| A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme | 1-gen-2007 | D'Ambrosio, R. L.; D'Andrea, Giovanna; Cafolla, A.; Faillace, F.; Margaglione, Maurizio | |
| A novel allele variant of the SERPINF2 gene responsible for severe plasmin inhibitor (α2-antiplasmin) deficiency in an Italian patient | 1-gen-2018 | Viganò, S; D'Andrea, G; Valle, Pd; Santacroce, R; Margaglione, M; D'Angelo, A. | |
| A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency. | 1-gen-2003 | D'Andrea, Giovanna; DI PERNA, P.; Brancaccio, V.; Faioni, E. M.; Castaman, G.; Cibelli, Giuseppe; DI MINNO, G.; Margaglione, Maurizio | |
| A Novel KCNN2 Variant in a Family with Essential Tremor Plus: Clinical Characteristics and In Silico Analysis | 1-gen-2023 | D'Apolito, Maria; Ceccarini, Caterina; Rosa, Savino; Adipietro, Iolanda; di Bari, Ighli; Santacroce, Rosa; Curcetti, Maria; D'Andrea, Giovanna; Croce, Anna-Irma; Cesarano, Carla; Polito, Anna Nunzia; Margaglione, Maurizio | |
| A NOVEL NONSENSE TET2 MUTATION IN A PATIENT WITH PRIMARY MYELOFIBROSIS. | 1-gen-2013 | D'Andrea, Giovanna; Dimatteo, C.; Girolamo, G. De; Longo, V.; Leccese, A.; Trunzo, R.; Santacroce, Rosa; Margaglione, Maurizio | |
| A polymorfism in VKORC1 gene is associated with an interindividual variability in the dose-anticoagulation effect of warfarin. | 1-gen-2005 | D'Andrea, Giovanna; Dambrosio, R. L.; P, DI ERNA .; Chetta, M.; Santacroce, Rosa; Brancaccio, V.; Grandone, E.; Margaglione, Maurizio | |
| A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin | 1-gen-2005 | D'Andrea, Giovanna; D'Ambrosio, Rl; Di Perna, P; Chetta, Massimiliano; Santacroce, Rosa; Brancaccio, V; Grandone, E; Margaglione, Maurizio |